Squarepoint’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-141
| Closed | -$71K | – | 2631 |
|
2021
Q3 | $71K | Sell |
141
-40
| -22% | -$20.1K | ﹤0.01% | 2069 |
|
2021
Q2 | $99K | Sell |
181
-124
| -41% | -$67.8K | ﹤0.01% | 2415 |
|
2021
Q1 | $188K | Buy |
305
+188
| +161% | +$116K | ﹤0.01% | 2177 |
|
2020
Q4 | $65K | Sell |
117
-16
| -12% | -$8.89K | ﹤0.01% | 2397 |
|
2020
Q3 | $85K | Buy |
+133
| New | +$85K | ﹤0.01% | 2152 |
|
2020
Q2 | – | Sell |
-191
| Closed | -$119K | – | 2253 |
|
2020
Q1 | $119K | Buy |
191
+135
| +241% | +$84.1K | ﹤0.01% | 1599 |
|
2019
Q4 | $59K | Buy |
+56
| New | +$59K | ﹤0.01% | 2294 |
|
2019
Q1 | – | Sell |
-89
| Closed | -$110K | – | 2198 |
|
2018
Q4 | $110K | Sell |
89
-87
| -49% | -$108K | ﹤0.01% | 1772 |
|
2018
Q3 | $431K | Buy |
+176
| New | +$431K | 0.01% | 1369 |
|